Research

Sandeep Dave, MD, MS

For most cancers, advances in genomics haven’t changed treatment strategies very much. Sandeep Dave, MD, MS, envisions making personalized treatment a reality for more patients, by developing and making better use of tools that already exist.

Illustration of COVID-19 virus

A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections — including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause the next pandemic. The findings were published in the journal Nature.

Tolu O. Oyesanya, PhD, RN and Karin Reuter-Rice, PhD, CPNP-AC, FCCM, FAAN

More than 5.3 million individuals — children and adults — permanently live with a brain injury-related disability, according to the Brain Injury Association of America. Two researchers from the Duke University School of Nursing, Tolu O. Oyesanya, PhD, RN, and  Karin Reuter-Rice, PhD, CPNP-AC, FCCM, FAAN, have devoted an aspect of their research toward better understanding the ramifications that brain injuries inflict on patients and their loved ones and how to give them the best health care possible.

Heather Whitson, MD, with patient

What if we could disable the defense mechanisms that enable cancer cells to evade treatment, or even control their genes to prevent them from developing into tumors in the first place? Can we enhance our brain’s ability to forestall damage from Alzheimer’s disease and other neurodegenerative conditions? Is it possible to develop a vaccine for everything?

Subscribe to Research